Ding L - Search Results

1

The role of Tim-3 blockade in the tumor immune microenvironment beyond T cells.

Zhang J, Wang L, Guo H, Kong S, Li W, He Q, Ding L, Yang B. Zhang J, et al. Among authors: ding l. Pharmacol Res. 2024 Nov;209:107458. doi: 10.1016/j.phrs.2024.107458. Epub 2024 Oct 11. Pharmacol Res. 2024. PMID: 39396768 Free article. Review.

2

Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages.

Yao Z, Zhang J, Zhang B, Liang G, Chen X, Yao F, Xu X, Wu H, He Q, Ding L, Yang B. Yao Z, et al. Among authors: ding l. Pharmacol Res. 2018 Jul;133:121-131. doi: 10.1016/j.phrs.2018.05.002. Epub 2018 May 3. Pharmacol Res. 2018. PMID: 29730267 Free article.

3

Insights into the role of derailed endocytic trafficking pathway in cancer: From the perspective of cancer hallmarks.

Guo H, Zhou C, Zheng M, Zhang J, Wu H, He Q, Ding L, Yang B. Guo H, et al. Among authors: ding l. Pharmacol Res. 2024 Mar;201:107084. doi: 10.1016/j.phrs.2024.107084. Epub 2024 Jan 29. Pharmacol Res. 2024. PMID: 38295915 Free article. Review.

4

Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.

Tariq M, Zhang J, Liang G, Ding L, He Q, Yang B. Tariq M, et al. Among authors: ding l. J Cell Biochem. 2017 Sep;118(9):2484-2501. doi: 10.1002/jcb.25895. Epub 2017 May 30. J Cell Biochem. 2017. PMID: 28106295 Review.

5

Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.

Tariq M, Zhang JQ, Liang GK, He QJ, Ding L, Yang B. Tariq M, et al. Among authors: ding l. Acta Pharmacol Sin. 2017 Nov;38(11):1501-1511. doi: 10.1038/aps.2017.124. Epub 2017 Oct 12. Acta Pharmacol Sin. 2017. PMID: 29022575 Free PMC article.

6

Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses.

Chen X, Pan X, Zhang W, Guo H, Cheng S, He Q, Yang B, Ding L. Chen X, et al. Among authors: ding l. Acta Pharm Sin B. 2020 May;10(5):723-733. doi: 10.1016/j.apsb.2019.09.006. Epub 2019 Sep 25. Acta Pharm Sin B. 2020. PMID: 32528824 Free PMC article. Review.

7

Tackling drug resistance in ovarian cancer with epigenetic targeted drugs.

Zhao L, Guo H, Chen X, Zhang W, He Q, Ding L, Yang B. Zhao L, et al. Among authors: ding l. Eur J Pharmacol. 2022 Jul 15;927:175071. doi: 10.1016/j.ejphar.2022.175071. Epub 2022 May 27. Eur J Pharmacol. 2022. PMID: 35636522 Review.

8

The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies.

Zhong T, Zhang W, Guo H, Pan X, Chen X, He Q, Yang B, Ding L. Zhong T, et al. Among authors: ding l. Acta Pharm Sin B. 2022 Apr;12(4):1761-1780. doi: 10.1016/j.apsb.2021.11.001. Epub 2021 Nov 5. Acta Pharm Sin B. 2022. PMID: 35847486 Free PMC article. Review.

9

The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy.

Zheng M, Zhang W, Chen X, Guo H, Wu H, Xu Y, He Q, Ding L, Yang B. Zheng M, et al. Among authors: ding l. Acta Pharm Sin B. 2023 Apr;13(4):1488-1497. doi: 10.1016/j.apsb.2022.10.027. Epub 2022 Nov 2. Acta Pharm Sin B. 2023. PMID: 37139414 Free PMC article. Review.

10

Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.

Pan X, Zhang W, Guo H, Wang L, Wu H, Ding L, Yang B. Pan X, et al. Among authors: ding l. Biochem Pharmacol. 2023 Jul;213:115596. doi: 10.1016/j.bcp.2023.115596. Epub 2023 May 16. Biochem Pharmacol. 2023. PMID: 37201875 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,330 results

Search Page

Filters